At the European Association of Nuclear Medicine (EANM) 2024 Congress, GE HealthCare unveils Aurora,[ii] a new dual head SPECT/CT with AI-powered technologies. The system is designed to help clinicians see and do more, aiming to help expand the range of procedures available for cardiac patients and provide support for conditions such as cancer and neurological disorders – all of which rely on early detection and precise localization of abnormalities are key for effective intervention..

在欧洲核医学协会（EANM）2024年大会上，GE HealthCare推出了Aurora，一种新的双头SPECT/CT，采用人工智能技术。该系统旨在帮助临床医生看到并做更多事情，旨在帮助扩大心脏病患者可用的手术范围，并为癌症和神经系统疾病等疾病提供支持-所有这些疾病都依赖于早期发现和异常的精确定位是有效干预的关键。。

“GE HealthCare is proud to be a leader in the integration of machine learning and AI advancements for more than a decade,” shares Jean-Luc Procaccini, President & CEO, Molecular Imaging and Computed Tomography, GE HealthCare. “We've witnessed firsthand how these technologies can address some of the industry's toughest challenges, such as data overload, physician burnout, and the need for real-time operational efficiency.

GE HealthCare分子成像和计算机断层扫描总裁兼首席执行官Jean-Luc Procaccini分享道：“GE HealthCare很骄傲能够成为十多年来机器学习和人工智能进步整合的领导者。”。“我们亲眼目睹了这些技术如何应对行业最严峻的挑战，如数据过载、医生倦怠以及对实时运营效率的需求。

With this experience top of mind, we designed Aurora to harness AI for exceptional image quality as well as enhanced workflow efficiency. It would be difficult to find a dual head hybrid system with more AI-powered solutions than Aurora – and we have full confidence clinicians will appreciate the difference.”.

凭借这一经验，我们设计了Aurora，以利用人工智能实现卓越的图像质量和增强的工作效率。很难找到比Aurora拥有更多人工智能解决方案的双头混合系统，我们完全有信心临床医生会欣赏这种差异。”。

As healthcare continues to shift toward precision medicine and personalized care, clinicians require more advanced SPECT/CT solutions. These nuclear medicine systems combine functional imaging from single-photon emission computed tomography (SPECT) with anatomical details from computed tomography (CT), offering clinicians a comprehensive view of both the physiological and structural aspects of diseases..

随着医疗保健继续转向精准医学和个性化护理，临床医生需要更先进的SPECT/CT解决方案。这些核医学系统将单光子发射计算机断层扫描（SPECT）的功能成像与计算机断层扫描（CT）的解剖学细节相结合，为临床医生提供了疾病生理和结构方面的全面视图。。

Aurora is designed to optimize both SPECT and CT technologies to capture gamma rays emitted by radioactive tracers. These findings are then turned into data which help create images showing the distribution of the tracer and enabling diagnoses across various care areas.

Aurora旨在优化SPECT和CT技术，以捕获放射性示踪剂发出的伽马射线。然后将这些发现转化为数据，帮助创建显示示踪剂分布的图像，并在各个护理领域进行诊断。

It also features GE HealthCare’s Revolution Ascend CT technology, offering additional design solutions to enable advanced capabilities that extend beyond routine imaging. This includes 40mm CT detector coverage – twice that of other hybrid systems[iii] – with a 75 cm-wide CT bore to help enhance patient comfort while facilitating high-speed scanning (0.35-second rotation speed)[iv] and offering up to 128 slices[v] for advanced procedures like coronary CT angiography..

。这包括40mm CT探测器的覆盖范围（是其他混合系统的两倍），75厘米宽的CT孔径有助于提高患者的舒适度，同时促进高速扫描（0.35秒的旋转速度），并为冠状动脉CT血管造影等高级程序提供多达128个切片。。

To help customers more easily process the vast amounts of data produced, GE HealthCare designed Aurora to unlock the full potential of digital and AI, offering new opportunities to help clinicians solve operational and diagnostic challenges as well as develop personalized approaches for better patient outcomes.

为了帮助客户更轻松地处理产生的大量数据，GE HealthCare设计了Aurora，以释放数字和人工智能的全部潜力，为帮助临床医生解决操作和诊断挑战以及开发个性化方法以获得更好的患者结果提供了新的机会。

These enhancements include:.

这些增强功能包括：。

Clarify DL[vi] deep learning image reconstruction, which is designed to enhance bone SPECT image quality performance, an important factor in increasing diagnostic confidence – in a clinical evaluation, Clarify DL's image resolution was rated as better in 98% of the exams;[vii]

Clarify DL[vi]深度学习图像重建，旨在提高骨SPECT图像质量性能，这是提高诊断信心的重要因素-在临床评估中，Clarify DL的图像分辨率在98%的检查中被评为更好；【七】

ASiR-V for lower dose (up to 82% relative to FBP), reduced noise levels up to 91% and improved spatial resolution at the same image noise;[viii]

ASiR-V用于较低剂量（相对于FBP高达82%），降低噪声水平高达91%，并在相同的图像噪声下提高空间分辨率；

SnapShot Freeze 2 for improvement in motion blur reduction while maintaining high spatial resolution for whole heart motion correction;[ix]

SnapShot Freeze 2用于改善运动模糊减少，同时保持高空间分辨率以进行全心运动校正；[九]

SwiftScan SPECT, which enables up to a 25% reduction in scan time or injected dose while maintaining lesion detectability;[x]

SwiftScan SPECT，可以在保持病变可检测性的同时，将扫描时间或注射剂量减少25%；[十]

Evolution, Aurora’s resolution recovery algorithm designed to overcome conventional imaging trade-offs by modelling the collimator/detector response – enables up to a 50% reduction in scan time or injected dose;[xi] and

Evolution是Aurora的分辨率恢复算法，旨在通过对准直器/探测器响应进行建模来克服传统的成像权衡，从而使扫描时间或注入剂量减少多达50%；【十一】和

SmartMar for excellent artifact-less imaging, which enables a reduction photon starvation, beam hardening, and streak artifacts caused by metal in the body.

SmartMar具有出色的无伪影成像功能，可减少体内金属引起的光子饥饿、光束硬化和条纹伪影。

Finally, Aurora is equipped with Effortless Workflow, which offers a set of efficiency solutions – including Auto Prescription and Smart Plan – enhanced by digital automation and design innovations to help ease technologists' intervention and intervention and help make exams smooth and comfortable for patients..

最后，Aurora配备了轻松的工作流程，它提供了一套高效的解决方案-包括自动处方和智能计划-通过数字自动化和设计创新来增强，以帮助减轻技术人员的干预和干预，并帮助患者顺利舒适地进行考试。。

“Aurora is the machine we were waiting for,” Bruno Vanderlinden, Radiation Physicist, Brussels University Hospital.[xii] “We can program the machine to run all the tests we do in nuclear medicine. It really is the Swiss army knife of imaging machines in nuclear medicine. We were able to set up acquisitions for 2-D, 3-D, and dynamic imaging, with high-quality CT scans and a significant reduction in radiation dose.”.

布鲁塞尔大学医院辐射物理学家布鲁诺·范德林登（BrunoVanderlinden）说：“极光是我们一直在等待的机器。”。[十二]“我们可以编程该机器来运行我们在核医学中所做的所有测试。它确实是核医学成像机器中的瑞士军刀。我们能够通过高质量的CT扫描和显着降低辐射剂量来建立二维，三维和动态成像的收购。”。

Click here for more information on Aurora and its digital and AI solutions.

单击此处了解有关Aurora及其数字和人工智能解决方案的更多信息。

Increasing patient access to precision care

增加患者获得精准护理的机会

In addition to Aurora, GE HealthCare is proud to showcase the latest additions to its Molecular Imaging portfolio at the EANM 2024 Congress. These solutions aim to enhance usability and increase the accessibility of precision care tools for the global practice of personalized medicine.

除了Aurora之外，GE HealthCare很荣幸在EANM 2024大会上展示其分子成像产品组合的最新添加。这些解决方案旨在提高个性化医疗全球实践中精准护理工具的可用性和可访问性。

As clinicians seek to practice more personalized medicine – including theranostics, a type of precision care that combines diagnostics and therapy – they increasingly look to leverage imaging techniques that more accurately inform diagnoses and measure functional and molecular responses to therapy.

。

In response, GE HealthCare aims to develop and deliver a range of products that support these efforts and empower global healthcare providers to address the needs of all patient populations:

作为回应，GE HealthCare旨在开发和提供一系列支持这些努力的产品，并使全球医疗保健提供者能够满足所有患者人群的需求：

MINItrace Magni with solid target technology:[xiii] Designed to be a small footprint, cost effective cyclotron for reliable, in-house production of commercial PET tracers and radiometals – like Gallium-68. When produced in combination with the company’s TRACERcenter – which is designed to serve as a complete PET radiopharmacy solution – the resulting radiopharmaceuticals can help physicians identify and diagnose clinical signs across care areas – including oncology, cardiology, and neurology.[xiv].

MINItrace Magni采用固体靶技术：[xiii]设计为一种占地面积小、成本效益高的回旋加速器，用于可靠的内部生产商用PET示踪剂和放射性物质，如镓-68。当与该公司的TRACERcenter（旨在作为完整的PET放射性药物解决方案）联合生产时，产生的放射性药物可以帮助医生识别和诊断整个护理领域的临床症状，包括肿瘤学、心脏病学和神经病学。【十四】。

Omni Legend 21 cm: A performance-oriented configuration of the Omni Legend PET/CT scalable platform designed to evolve with healthcare system needs across care areas, including: shorter scan times and lower doses[xv] without compromising image quality in oncology; support for increasing PET amyloid imaging in Alzheimer's diagnosis and treatment follow up in neurology; and exceptional cardiac diagnostics, accommodating a range of tracers – including fast decay and emerging tracers – in cardiology..

Omni Legend 21 cm:Omni Legend PET/CT可扩展平台的面向性能的配置，旨在随着护理领域的医疗系统需求而发展，包括：更短的扫描时间和更低的剂量，而不会影响肿瘤学的图像质量；支持在神经病学的阿尔茨海默病诊断和治疗随访中增加PET淀粉样蛋白成像；以及出色的心脏诊断，可在心脏病学中容纳一系列示踪剂，包括快速衰变和新兴示踪剂。。

Omni Legend mobile: A portable, all-in-one PET/CT solution that further extends the capabilities of Omni Legend to regional or local scan centers, helping increase access to advanced imaging while helping reduce travel burdens, especially for more vulnerable or remote patient communities.

。

MIM Software: A comprehensive software solution portfolio designed to boost efficiency and promote precision care. Key products, including MIM Encore and MIM SurePlan MRT, offer clinicians and researchers intuitive image processing and interpretation, AI-based image segmentation, tumor burden quantitation, practical dosimetry, workflow standardization and automation — all in a single unified vendor-neutral platform..

MIM软件：一个全面的软件解决方案组合，旨在提高效率和促进精准护理。关键产品，包括MIM Encore和MIM SurePlan MRT，为临床医生和研究人员提供直观的图像处理和解释，基于AI的图像分割，肿瘤负荷定量，实用剂量测定，工作流程标准化和自动化-所有这些都在一个统一的供应商中立平台中。。

Driven by its mission to create a world where healthcare has no limits, GE HealthCare is also a proud collaborator with and trusted partner to leading global health and academic institutions around the world. Most recently, the company announced:

GE healthcare的使命是创造一个医疗保健没有限制的世界，在这一使命的推动下，GE healthcare还是全球领先的医疗保健和学术机构的骄傲合作者和值得信赖的合作伙伴。最近，该公司宣布：

University Medicine Essen’s new Theranostics Center of Excellence: With the aim of increasing access to precision care, GE HealthCare is proud to collaborate with University Medicine Essen (UME) in the establishment of a new Theranostics Center of Excellence. The Center will be outfitted with the latest GE HealthCare technologies and solutions to support the clinical practice and advanced research of more personalized approaches to cancer care in Germany and around the world..

埃森大学医学院新的卓越治疗中心：为了增加获得精准护理的机会，GE HealthCare很荣幸与埃森大学医学院（UME）合作建立新的卓越治疗中心。该中心将配备最新的通用电气医疗保健技术和解决方案，以支持德国和世界各地更个性化的癌症护理方法的临床实践和先进研究。。

Thera4Care: An initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The €25.3 million project gathers 29 partners from top European institutions – including GE HealthCare – to expand the use of theranostics in the region by creating, implementing, and disseminating standardized, scalable methods for the production, detection, and monitoring of key theranostic isotopes, from the manufacturing and early delivery of diagnostics through to therapy..

Thera4Care：旨在彻底改变治疗学的使用，以扩大欧洲患者的使用范围。该2530万欧元的项目汇集了包括GE HealthCare在内的欧洲顶级机构的29位合作伙伴，通过创建、实施和传播标准化、可扩展的方法来生产、检测和监测关键的治疗同位素，从诊断的制造和早期交付到治疗，从而扩大该地区治疗诊断的使用。。

For more information on GE HealthCare’s impressive Molecular Imaging and MIM Software solutions, please visit gehealthcare.com and mimsoftware.com or stop by the company’s booth at the European Association of Nuclear Medicine 2024 Congress in Hamburg, Germany.

有关GE HealthCare令人印象深刻的分子成像和MIM软件解决方案的更多信息，请访问gehealthcare.com和mimsoftware.com，或在德国汉堡举行的欧洲核医学协会2024年大会上参观该公司的展位。

###

###

[i] “GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations.” GE HealthCare. 22 May 2024. https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-tops-list-for-third-year-in-a-row-with-highest-number-of-ai-enabled-medical-device-authorizations.

[i] “GE HealthCare连续第三年排名榜首，拥有最多的人工智能医疗设备授权。”GE HealthCare。2024年5月22日。https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-tops-list-for-third-year-in-a-row-with-highest-number-of-ai-enabled-medical-device-authorizations.

[ii] Aurora is CE marked. Available for sale in EU countries. Not approved or cleared by the US FDA. Not available for sale in the U.S and other non-EU countries.

极光是CE标记的。可在欧盟国家销售。未经美国FDA批准或批准。不可在美国和其他非欧盟国家销售。

[iii] Aurora as compared to NM/CT 870 DR with Optima CT 540.

[iii]极光与NM/CT 870 DR和Optima CT 540相比。

[iv] 0.35 rotation speed is optional. 0.5 second rotation speed is standard.

[四]0.35转速可选。标准转速为0.5秒。

[v] 128 slices with the overlapped reconstruction option.

[v] 128个切片，具有重叠重建选项。

[vi] Clarify DL is CE marked as part of Xeleris V. 510(k) pending at the US FDA. Not available for sale in the United States.

[vi]澄清DL被CE标记为Xeleris V.510（k）的一部分，正在美国FDA进行审理。不可在美国销售。

[vii] As demonstrated in clinical evaluationin which 127 exams were rated by total of 9 physicians. Each exam was reconstructed with both Clarify DL and the existing factory reconstruction preset and evaluated by 3 of the physicians.

如临床评估所示，共有9名医生对127项考试进行了评分。。

[viii] ASiR-V reduces dose by 50% to 82% relative to FBP at the same image quality, as defined by low contrast detectability. ASiR-V reduces image noise up to 91% at the same dose. ASiR-V improves spatial resolution up to 2.07X (107%) at same image noise. In clinical practice, the use of ASiR-V may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice.

根据低对比度可检测性的定义，在相同的图像质量下，ASiR-V相对于FBP将剂量降低50%至82%。ASiR-V在相同剂量下可将图像噪声降低高达91%。在相同的图像噪声下，ASiR-V将空间分辨率提高到2.07倍（107%）。在临床实践中，根据临床任务，患者大小，解剖位置和临床实践，使用ASiR-V可能会减少CT患者的剂量。

A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low Contrast Detectability (LCD), Image Noise, Spatial Resolution and Artifact were assessed using reference factory protocols comparing ASiR-V and FBP.

应咨询放射科医生和物理学家，以确定适当的剂量，以获得特定临床任务的诊断图像质量。使用比较ASiR-V和FBP的参考工厂协议评估了低对比度可检测性（LCD），图像噪声，空间分辨率和伪影。

The LCD measured in 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using model observer method..

LCD以0.625 mm切片进行测量，并使用MITA CT IQ幻影（CCT183，幻影实验室），使用模型观察者方法测试头部和身体模式。。

[ix] The SnapShot Freeze 2 algorithm provides up to 6x improvement in motion blur reduction while maintaining high spatial resolution. This is demonstrated in cardiac phantom testing. The reduction in motion artifacts is comparable to a 0.058s Equivalent Gantry Rotation Speed with effective temporal resolution of 29 msec, as demonstrated in mathematical phantom testing..

[ix]SnapShot Freeze 2算法在保持高空间分辨率的同时，在减少运动模糊方面提高了6倍。这在心脏体模测试中得到了证明。运动伪影的减少与0.058s等效机架旋转速度相当，有效时间分辨率为29毫秒，如数学模型测试所示。。

[x] Compared to LEHR collimator, with Step & Shoot scan mode. As demonstrated in phantom testing using a bone scan protocol, Evolution processing and a model observer. Because model observer results may not always match those from a human reader, the actual time/ dose reduction depends on the clinical task, patient size, anatomical location and clinical practice.

[x] 与退火窑准直器相比，具有步进和拍摄扫描模式。如使用骨骼扫描协议，进化处理和模型观察者进行的幻影测试所示。由于模型观察者的结果可能并不总是与人类读者的结果相匹配，因此实际的时间/剂量减少取决于临床任务，患者规模，解剖位置和临床实践。

A radiologist should determine the appropriate scan time/dose for the particular clinical task..

放射科医生应确定特定临床任务的适当扫描时间/剂量。。

[xi] In clinical practice, Evolution options1a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit1b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site..

在临床实践中，建议在咨询核医学医师，物理学家和/或应用专家后使用进化选项1a（骨骼进化，心脏进化，骨骼平面进化）和进化工具Kit1b，以确定适当的剂量或扫描时间减少，以获得特定临床任务的诊断图像质量，具体取决于临床现场采用的方案。。

a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison..

a、 进化选项-进化声明得到了使用默认工厂协议模拟计数统计数据以及99mTc基放射性示踪剂与退火窑准直器在拟人体模或真实NCAT-SIMSET体模上成像的支持，然后进行定量和定性图像比较。。

b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM..

b、 Evolution Toolkit-Evolution Toolkit的声明得到了使用基于各种放射性示踪剂和准直器的病变模拟体模图像模拟全计数统计数据的支持，并表明使用Evolution Toolkit重建的SPECT图像质量提供了等效的临床信息，但与使用FBP/OSEM重建的图像相比，具有更好的信噪比，对比度和病变分辨率。。

[xii] The statement by the GE Healthcare customer described here is based on their own opinions and experiences and on results that were achieved in the customer’s unique setting. Since there is no typical hospital and many variables exist, such as hospital size, case mix, etc., there can be no guarantee that other customers will achieve the same results..

【xii】此处描述的GE Healthcare客户声明基于他们自己的观点和经验以及在客户独特环境中取得的成果。由于没有典型的医院，并且存在许多变量，例如医院规模，病例组合等，因此无法保证其他客户会获得相同的结果。。

[xiii] Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not CE marked.

【十三】代表正在进行的研究和开发工作的发展中的技术。这些技术不是产品，也可能永远不会成为产品。没有CE标记。

[xiv] MINItrace Magni is designed to produce the following radionuclides for use across care areas: 18F, 11C, 13N, 15O, 68Ga, 89Zr, 61/64Cu and more.

[十四]MINItrace Magni旨在生产以下放射性核素，用于护理区域：18F、11C、13N、15O、68Ga、89Zr、61/64Cu等。

[xv] Omni Legend enables up to 40% PET dose reduction or up to 32% PET scan time reduction compared to Discovery MI 20 cm. As demonstrated in phantom testing

[十五]与Discovery MI 20厘米相比，Omni Legend可以减少多达40%的PET剂量或减少多达32%的PET扫描时间。如幻影测试所示

About GE HealthCare Technologies Inc.

。

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

GE HealthCare是全球领先的医疗技术、药物诊断和数字解决方案创新者，致力于提供集成的解决方案、服务和数据分析，使医院更高效、临床医生更有效、治疗更精确，患者更健康、更快乐。

Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring.

GE HealthCare为患者和提供者服务了125多年，正在推进个性化、互联化和富有同情心的护理，同时简化患者跨越护理路径的旅程。我们的成像、超声波、患者护理解决方案和药物诊断业务共同帮助改善患者护理，从诊断到治疗再到监测。

We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits. .

我们是一家价值196亿美元的企业，拥有约51000名员工，致力于创造一个医疗保健无限的世界。。

Follow us on LinkedIn, X , Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.

关注我们‡LinkedIn，‡X，‡Facebook，Instagram和Insights‡了解最新消息，或访问我们的网站‡https://www.gehealthcare.com/ 了解更多信息。

Media contacts

媒体联系人

Margaret Steinhafel

玛格丽特·斯坦哈费尔

Global Communications Director, Molecular Imaging & Computed Tomography

分子成像和计算机断层扫描全球通信总监

GE HealthCare

GE HealthCare

+1 608 381 8829

+1 608 381 8829

[email protected]

[受电子邮件保护]

Source: gehealthcare.com

来源：gealthcare.com